Searchable abstracts of presentations at key conferences on calcified tissues

ba0002p174 | (1) | ICCBH2013

Elite child athlete is our future: bone lumbar spine adaptation in Egyptian children monofin athletes

Abouzeid Magdy

Objectives: Over the last several years, the Monofin has appeared with increasing regularity at swim practices throughout the world. Physical activity during childhood is advocated as one strategy for enhancing peak bone mass as a means to reduce osteoporosis. Clinical studies have found that non-impact sport like swimming are associated with normal to low bone densities. Little is known about the influence of monofin swimming during childhood on lumbar spine mass. This is a n...

ba0005oc6.3 | Development and differentiation (or Aging) | ECTS2016

The critical biomechanical role of Lipocalin 2 in the crosstalk between endothelium and osteoblasts in unloading conditions.

Veeriah Vimal , Capulli Mattia , Zanniti Angelo , Chatterjee Suvro , Rucci Nadia , Teti Anna

Angiogenesis and osteogenesis are tightly linked and dependent on each other. Lipocalin 2 (LCN2) is a mechanoresponding adipokine, strongly upregulated in osteogenic cells subjected to microgravity (0.08–0.008 g), in which it impairs osteogenesis and upregulates the osteoclastogenic cytokine, RANKL. We investigated the role of LCN2 in the crosstalk between angiogenesis and osteogenesis in simulated microgravity conditions as a model of mechanical unloading. Mouse and huma...

ba0005p50 | Bone development/growth and fracture repair | ECTS2016

Prostaglandin IP agonist promotes osteoblastic differentiation and BMP induced bone formation

Kanayama Sadaaki , Kaito Takashi , Kashii Masafumi , Makino Takahiro , Morimoto Tokimitsu , Kitaguchi Kazuma , Ishiguro Hiroyuki , Yoshikawa Hideki

Introduction: A synthetic prostacyclin IP receptor agonist (ONO-1301) has been reported to induce the production of endogenous HGF and VEGF in fibroblasts by stimulating cAMP production.Materials and methods: In vitro; murine primary osteoblasts and cell line (ST2, MC3T3-E1, C2C12) were treated with BMP-2 (0–100 ng/ml) and ONO-1301 (0–10−6 M). ALP assay and cell proliferation assay were performed. In vivo analysis, Col...

ba0006p081 | (1) | ICCBH2017

Bone age determination using dual-energy X-ray absorptiometry

Alshamrani Khalaf , Offiah Amaka , kruger Elzene

Objective: To assess whether hand-wrist dual-energy x-ray absorptiometry (DXA) can replace radiographs for bone age assessment using the Greulich & Pyle (G&P) and/or Tanner & Whitehouse (TW3) methods.Methodology: Purposive sampling was used to include a total of 20 patients identified from an Endocrine Clinic; two males and two females from each of 5 age groups (<5; 5 to 7; 8 to 10; 11 to 13; 14 to 16 years). Bone age as determined from D...

ba0006p155 | (1) | ICCBH2017

Dietary protein is associated with bone adaptations and performance of pre-adolescents

Stampoulis Theodoros , Leontsini Diamanda , Avloniti Alexandra , Draganidis Dimitrios , Chatzinikolaou Athanasios , Venetsanou Fotini , Deli Chariklia , Vlachopoulos Dimitris , Gracia-Marco Luis , Michalopoulou Maria , Jamurtas Athanasios , Fatouros Ioannis , Kambas Antonis

Objectives: Nutrition in childhood is a major factor for healthy living during adulthood. Bone mass is influenced immensely by nutritional intake, especially protein intake which is very important for bone matrix and the integrity of skeletal structure. This study aimed to identify the effects of dietary protein intake on bone mineral density (BMD), bone mineral content (BMC) and performance of children aged 6–12 years old.Methods: A repeated measur...

ba0007oc25 | (1) | ICCBH2019

TransCon CNP: Potential for a once weekly novel therapy in children with achondroplasia

Bharucha Kamal , Ota Sho , Christoffersen Eva Dam , Mygind Per , Viuff Dorthe , Leff Jonathan

Objectives: Achondroplasia (ACH), the most common form of human dwarfism, is caused by a gain-of-function mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, a key negative regulator of endochondral ossification. C-type natriuretic peptide (CNP) inhibits the FGFR3 pathway and thereby promotes proliferation and differentiation of chondrocytes to promote bone growth. TransCon CNP is a prodrug designed to provide continuous exposure to CNP to optimize efficacy with ...

ba0002op9 | (1) | ICCBH2013

Anticalciuric effect of recombinant PTH in patients with activating mutations of the calcium-sensing receptor causing autosomal dominant hypocalcaemia--hypercalciuria

Rothenbuhler Anya , Allgrove Jeremy , Coutant Regis , Kapelari Klaus , Bessenay Lucie , Isnard Myriam , Hogler Wolfgang , Linglart Agnes , ESPE Working Group on Bone and Growth Plate

Background: Most patients with hypoparathyroidism are controlled under conventional treatment with calcium and vitamin D analogues. However, this treatment may be difficult to manage, especially in patients with ADHH who have an increased risk of nephrocalcinosis and chronic renal insufficiency. ADHH is caused by activating mutations in the calcium-sensing receptor (CaSR) resulting in suppressed PTH secretion and decreased calcium reabsorption within the thick ascending limb o...

ba0003pp171 | Cell biology: osteoclasts and bone resorption | ECTS2014

The purinergenic receptor P2Y14 is essential for RANKL-induced osteoclastogenesis

Park Jin Hee , Jung Eutteum , Lee Soo Young

The P2Y14 (purinergic receptor P2Y, G protein coupled, 14) receptor for UDP-glucose and other UDP-sugars has been implicated in the regulation of the stem cell compartment as well as neuroimmune function. However, the role of P2Y14 in osteoclast formation is completely unknown. We found that RANKL selectively induced P2Y14 among seven mammalian P2Y receptors when analysed at both the mRNA and protein level, but inhibitors of the MAP pathway suppressed induction of P2Y14 protei...

ba0004p103 | (1) | ICCBH2015

Gait assessment in children with childhood hypophosphatasia: impairments in muscle strength and physical function

Phillips Dawn , Griffin Donna , Przybylski Tracy , Morrison Erica , Reeves Amy , Vallee Marc , Fujita Kenji , Madson Katherine , Whyte Michael

Objectives: Hypophosphatasia (HPP) is the rare inherited metabolic disease caused by low tissue nonspecific alkaline phosphatase activity. HPP manifests a wide spectrum of complications, which may include HPP-related rickets and compromised physical function in children.Methods: We report on clinical gait assessments based on archival video recordings of six children with onset of HPP symptoms at ≧6 months and documented HPP-related skeletal abnor...

ba0001oc6.4 | Mineralisation and energy metabolism | ECTS2013

Inhibition of PTH-induced vasorelaxation modulates its anabolic action

Gohin Stephanie , Chenu Chantal , Pitsillides Andrew , Arnett Timothy , Marenzana Massimo

The relationship between bone formation and blood flow is unclear. Recently, PTH was reported to activate production of nitric oxide (NO), a potent vasorelaxing agent, in endothelial cells and we and others have confirmed a strong vasorelaxing action of PTH in vivo in the mouse. Here, we tested the hypothesis that a potent NO synthase inhibitor (L-NAME: NG-nitro-L-arginine methyl ester) may alter the effect of intermittent PTH (iPTH) on b...